Nasdaq · CIK 0000873303
SRPT Sarepta Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 34 d ago. Close $17.85 on Oct 9, 2026, +20% from the 52-week low and -27% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
SRPTOct 9, 2026 · close 17.85
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Sarepta Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Hans Lennart Rudolf Wigzell director sell | $1.3M 10,500 shares | -31% | - | |
| 40Moderate | Kathryn Jean Boor director sell | $205k 1,636 shares | -22% | - |
Congressional trades
1 trade in SRPT disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Gilbert Ray Cisneros, Jr. House · D-CA | Sale | SRPT Sarepta Therapeutics, Inc. - Common Stock | $1,001 to $15k | Apr 14, 2025 / May 6, 2025 22 days after the trade | Clerk |
Transactions
The last 57 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Louise Rodino-Klapac President, R&D and Tech Ops | FTax withholding Common Stock | -21,423 | $22.22 | $476k | 203,900 | 34 d ago |
| Sep 4, 2026 | Cristin Rothfuss EVP, General Counsel | FTax withholding Common Stock | -22,025 | $22.22 | $489k | 115,519 | 34 d ago |
| Sep 4, 2026 | Ryan Ho-Yan Wong Chief Financial Officer | FTax withholding Common Stock | -13,272 | $22.22 | $295k | 121,792 | 34 d ago |
| Sep 4, 2026 | Ian Michael Estepan Chief Operating Officer | FTax withholding Common Stock | -24,799 | $22.22 | $551k | 177,184 | 34 d ago |
| May 16, 2025 | Richard Barry director | MOption exercise Common Stock | +12,350 | $32.63 | $403k | 2,966,667 | May 19, 2025 |
| May 16, 2025 | Richard Barry director | MOption exercise Stock Option (right to buy)derivative | -12,350 | $0.00 | $0 | 0 | May 19, 2025 |
| May 13, 2025 | Richard Barry director | MOption exercise Common Stock | +9,746 | $25.18 | $245k | 2,943,817 | May 15, 2025 |
| May 13, 2025 | Richard Barry director | MOption exercise Common Stock | +10,500 | $13.71 | $144k | 2,954,317 | May 15, 2025 |
| May 13, 2025 | Richard Barry director | MOption exercise Stock Option (right to buy)derivative | -9,746 | $0.00 | $0 | 0 | May 15, 2025 |
| May 13, 2025 | Richard Barry director | MOption exercise Stock Option (right to buy)derivative | -10,500 | $0.00 | $0 | 0 | May 15, 2025 |
| Mar 10, 2025 | Kathryn Jean Boor director | AGrant or award Common Stock | +2,383 | - | - | 8,263 | Mar 11, 2025 |
| Mar 7, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Common Stock | +5,500 | - | - | 58,277 | Mar 11, 2025 |
| Mar 10, 2025 | Deirdre P Connelly director | AGrant or award Common Stock | +2,383 | - | - | 5,225 | Mar 11, 2025 |
| Mar 10, 2025 | Michael Andrew Chambers director | AGrant or award Common Stock | +2,383 | - | - | 10,660 | Mar 11, 2025 |
| Mar 10, 2025 | Richard Barry director | AGrant or award Common Stock | +2,383 | $0.00 | $0 | 2,934,071 | Mar 11, 2025 |
| Mar 10, 2025 | Bilal Arif Chief Tech Ops Officer | FTax withholding Common Stock | -523 | $100.13 | $52k | 24,224 | Mar 11, 2025 |
| Mar 10, 2025 | M Kathleen Behrens director | AGrant or award Common Stock | +2,383 | - | - | 193,476 | Mar 11, 2025 |
| Mar 10, 2025 | Kathryn Jean Boor director | AGrant or award Stock Options (right to buy)derivative | +4,792 | $0.00 | $0 | 4,792 | Mar 11, 2025 |
| Mar 10, 2025 | Deirdre P Connelly director | AGrant or award Stock Options (right to buy)derivative | +4,792 | $0.00 | $0 | 4,792 | Mar 11, 2025 |
| Mar 10, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -1,051 | $100.13 | $105k | 57,226 | Mar 11, 2025 |
| Mar 10, 2025 | Bilal Arif Chief Tech Ops Officer | AGrant or award Common Stock | +8,276 | - | - | 32,500 | Mar 11, 2025 |
| Mar 10, 2025 | M Kathleen Behrens director | AGrant or award Stock Option (right to buy)derivative | +4,792 | $0.00 | $0 | 4,792 | Mar 11, 2025 |
| Mar 10, 2025 | Michael Andrew Chambers director | AGrant or award Stock Options (right to buy)derivative | +4,792 | $0.00 | $0 | 4,792 | Mar 11, 2025 |
| Mar 10, 2025 | Bilal Arif Chief Tech Ops Officer | AGrant or award Stock Options (right to buy)derivative | +16,644 | $0.00 | $0 | 16,644 | Mar 11, 2025 |
| Mar 10, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -2,890 | $100.13 | $289k | 54,336 | Mar 11, 2025 |
| Mar 10, 2025 | Richard Barry director | AGrant or award Stock Options (right to buy)derivative | +4,792 | $0.00 | $0 | 4,792 | Mar 11, 2025 |
| Mar 10, 2025 | Ian Michael Estepan Chief Financial Officer | AGrant or award Common Stock | +8,276 | - | - | 62,612 | Mar 11, 2025 |
| Mar 7, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Performance Stock Unitsderivative | -5,500 | $0.00 | $0 | 0 | Mar 11, 2025 |
| Mar 10, 2025 | Ian Michael Estepan Chief Financial Officer | AGrant or award Stock Options (right to buy)derivative | +16,644 | $0.00 | $0 | 16,644 | Mar 11, 2025 |
| Mar 6, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Common Stock | +17,500 | - | - | 62,456 | Mar 10, 2025 |
| Mar 6, 2025 | Bilal Arif Chief Tech Ops Officer | MOption exercise Common Stock | +17,500 | - | - | 33,782 | Mar 10, 2025 |
| Mar 7, 2025 | Bilal Arif Chief Tech Ops Officer | FTax withholding Common Stock | -508 | $103.70 | $53k | 33,274 | Mar 10, 2025 |
| Mar 7, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -585 | $103.70 | $61k | 61,871 | Mar 10, 2025 |
| Mar 7, 2025 | Bilal Arif Chief Tech Ops Officer | FTax withholding Common Stock | -8,527 | $103.70 | $884k | 24,747 | Mar 10, 2025 |
| Mar 7, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -9,094 | $103.70 | $943k | 52,777 | Mar 10, 2025 |
| Mar 6, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Performance Stock Unitsderivative | -17,500 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 6, 2025 | Bilal Arif Chief Tech Ops Officer | MOption exercise Performance Stock Unitsderivative | -17,500 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 4, 2025 | Bilal Arif Chief Tech Ops Officer | FTax withholding Common Stock | -281 | $101.34 | $28k | 16,515 | Mar 6, 2025 |
| Mar 4, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -1,370 | $101.34 | $139k | 44,956 | Mar 6, 2025 |
| Mar 4, 2025 | Bilal Arif Chief Tech Ops Officer | FTax withholding Common Stock | -233 | $101.34 | $24k | 16,282 | Mar 6, 2025 |
| Mar 3, 2025 | Bilal Arif Chief Tech Ops Officer | FTax withholding Common Stock | -719 | $103.77 | $75k | 16,796 | Mar 4, 2025 |
| Mar 3, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -557 | $103.77 | $58k | 46,326 | Mar 4, 2025 |
| Feb 11, 2025 | Bilal Arif Chief Tech Ops Officer | AGrant or award Performance Restricted Stock Unitsderivative | +3,500 | $0.00 | $0 | 17,500 | Feb 13, 2025 |
| Feb 11, 2025 | Ian Michael Estepan Chief Financial Officer | AGrant or award Performance Restricted Stock Unitsderivative | +3,500 | $0.00 | $0 | 17,500 | Feb 13, 2025 |
| Jan 29, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Common Stock | +14,267 | $12.00 | $171k | 47,963 | Jan 31, 2025 |
| Jan 29, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Common Stock | +1,533 | $12.00 | $18k | 49,496 | Jan 31, 2025 |
| Jan 29, 2025 | Ian Michael Estepan Chief Financial Officer | FTax withholding Common Stock | -2,613 | $117.51 | $307k | 46,883 | Jan 31, 2025 |
| Jan 29, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -14,267 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Jan 29, 2025 | Ian Michael Estepan Chief Financial Officer | MOption exercise Stock Option (right to buy)derivative | -1,533 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Dec 27, 2024 | Ian Michael Estepan Chief Financial Officer | GGift Common Stock | -250 | $0.00 | $0 | 33,696 | Dec 30, 2024 |
| Dec 12, 2024 | Hans Lennart Rudolf Wigzell director | MOption exercise Common Stock | +10,500 | $13.71 | $144k | 33,340 | Dec 16, 2024 |
| Dec 12, 2024 | Hans Lennart Rudolf Wigzell director | SOpen-market sale Common Stock | -10,500 | $124.84 | $1.3M | 22,840 | Dec 16, 2024 |
| Dec 12, 2024 | Hans Lennart Rudolf Wigzell director | MOption exercise Stock Options (right to buy)derivative | -10,500 | $0.00 | $0 | 0 | Dec 16, 2024 |
| Dec 5, 2024 | Kathryn Jean Boor director | SOpen-market sale Common Stock | -1,636 | $125.55 | $205k | 5,880 | Dec 6, 2024 |
| Nov 26, 2024 | Cristin Rothfuss EVP, General Counsel | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 13,817 | Nov 29, 2024 |
| Nov 26, 2024 | Cristin Rothfuss EVP, General Counsel | AGrant or award Stock Option (right to buy)derivative | +4,000 | $0.00 | $0 | 4,000 | Nov 29, 2024 |
| Nov 18, 2024 | Louise Rodino-Klapac Head of R&D, CSO | FTax withholding Common Stock | -4,558 | $102.89 | $469k | 67,630 | Nov 20, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bilal ArifChief Tech Ops Officer
- M Kathleen Behrensdirector
- Richard Barrydirector, ceo, president, officer
- Kathryn Jean Boordirector
- Michael Andrew Chambersdirector
- Deirdre P Connellydirector
- Ian Michael EstepanChief Operating Officer
- Louise Rodino-KlapacPresident, R&D and Tech Ops
- Cristin RothfussEVP, General Counsel
- Hans Lennart Rudolf Wigzelldirector
- Ryan Ho-Yan WongChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.